Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
about
Oxcarbazepine for neuropathic painOxcarbazepine for neuropathic painNeuropathic pain: a practical guide for the clinicianEvidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitatiGuidelines in the management of diabetic nerve pain: clinical utility of pregabalin.Diabetic neuropathy: mechanisms to managementTreating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & RehabilitationEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.Treatment of painful diabetic neuropathyBurning through the pain: treatments for diabetic neuropathy.EFNS guidelines on pharmacological treatment of neuropathic pain.Diabetic neuropathy: new strategies for treatment.New perspectives on the management of diabetic peripheral neuropathic pain.Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain.Blocking sodium channels to treat neuropathic pain.Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review.Oxcarbazepine in neuropathic pain.Voltage-gated sodium channel blockers for the treatment of neuropathic pain.Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.Predictors of premature discontinuation of treatment in multiple disease statesPain associated with diabetic peripheral neuropathy: a review of available treatmentsSodium channel blockers for the treatment of neuropathic pain.Sodium channel blockers for neuropathic pain.Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety.Clinical Approach to the Treatment of Painful Diabetic Neuropathy.Adjuvant analgesics in cancer pain: a review.Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy.Diabetic neuropathy and oxidative stress: therapeutic perspectives.Update on neuropathic pain treatment: ion channel blockers and gabapentinoids.An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis.Choosing drugs for the treatment of diabetic neuropathy.Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy.Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study.Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials.Oxcarbazepine for neuropathic pain.
P2860
Q24198916-0CCD8A01-893C-4E7D-96E6-D11579B13AD4Q24240708-EC801390-DBE2-4FED-9281-8CB01001212AQ24553796-B05D369D-7087-42E9-A554-3555FF285BA5Q24632313-E3E28CFE-C11D-4EDF-A9D2-251278F51A0AQ30537158-EE294917-D73D-4683-BE8A-8BA47EA116C9Q33554384-7D71A51C-DB87-430A-B1CB-25F9AEE9FBA3Q33583006-AA278B4E-9105-41A2-9061-5F8E3875824FQ33870062-571E48D7-78F0-4857-9118-A95E7F1BAF43Q34110857-E5F559F3-945D-4F91-B78A-8D6078DC61F0Q34456265-DC9D9C7C-B500-4AC0-8F41-FB71C8F3AB81Q34485306-CBEC695C-222F-48E5-9F2B-CF1CB9A6C147Q34573607-27C9FB25-2090-47F9-89C3-A784AFD9C889Q34641965-592BEC13-B602-46EE-BC5B-9DEF6F263EEFQ36632037-50AA1397-6AAA-4388-8C8E-43215DDBFF2AQ36697477-AE483761-B973-4DB6-9DBB-BFE595E4C560Q36734922-72DF7998-F721-4FC6-8412-BC90CC9B6355Q36917017-5F77E2ED-3012-4780-B1D9-7566E833D881Q36964709-5BBD93AE-C453-405F-AF8A-C2B7D27373FFQ36998857-6F055AB9-9C48-40F5-913D-5BC6308D9829Q37283665-EFDDD9DB-5119-41E2-9E26-D61957D51F88Q37423705-3CFBA7C3-51A3-49A3-8E24-683885A68496Q37596278-5623AC4E-830A-4F25-BDCF-8E1049113059Q37605350-66B8BE67-95AD-444C-BF56-A41CAB958824Q37729164-49429E69-35F9-4C6C-9919-F4352852535EQ37846329-B220CA79-A1DC-4616-919C-2647F6247FD2Q37895130-270E4E09-3AE0-400C-9F5E-4977A931DF76Q37895398-A6E97BA3-F953-4886-B8C5-CC73FF6B1E85Q38093664-2006283C-4A79-4C36-9375-84DFE6A705CFQ38112117-C2A7D168-7B03-4E04-9574-B3FCA47DDE05Q38124283-6830820C-2F42-4BF2-9347-3F5A6A6D9549Q38307489-A71F17CF-A99E-46F4-AA73-A0A670AD03F0Q38544804-B5B25CCE-75BD-4086-91D9-D1D0ACE1C530Q38652570-04C8BAB9-CC29-454D-BC08-141D958A9C95Q39274579-46E4B0BD-84A9-4D18-9C91-39B571C4BCA1Q39339956-9A319681-63F6-4128-8BD4-ED29184898AFQ39351750-F6113941-C890-4C93-8720-29187611EAA3Q43075748-717B1B5A-4574-4FB6-AFEB-769BFD01D34FQ47376802-3E6F6171-CB96-464E-8A26-6E140F74E398
P2860
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
@en
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
@nl
type
label
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
@en
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
@nl
prefLabel
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
@en
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
@nl
P2093
P2860
P1476
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
@en
P2093
Jennifer Mazzola
Margaret Hopwood
Said Beydoun
Sunil Dogra
P2860
P304
P356
10.1016/J.EJPAIN.2004.11.006
P577
2004-12-18T00:00:00Z